Weight Loss Clinic Marketing and the GLP-1 Ad Rules for 2026

On September 28, we sat down with a GLP-1 clinic we work with and settled, after a trademark check, exactly how its injection pen gets described in content. Say “dosing pen” or “injection pen.” Say “a very fine needle.” Say “you set the dose your provider prescribes and monitors.” Never say “auto injector” or “auto pen,” never borrow another company’s pen name, and never say “painless.”

Five days earlier, the twelve reel scripts we’d written for the clinic went through our script generator. It refuses to build if the public copy says “doctor,” “Dr.” or “physician,” names semaglutide, tirzepatide, Ozempic, Wegovy, Mounjaro or Zepbound, uses “cure,” “guarantee,” “miracle,” “detox,” “FDA approved,” “same as” or “before and after,” or puts a number after “lose.”

Several of those rules come straight from a statute, a regulator or an ad platform. The rest are judgment calls we’d defend in front of any of them.

Here’s what Meta, Google, FDA, the FTC and California law say, read on the source pages in late September 2026, and the working rules we built on top of them. It’s how we run a regulated account, not legal advice, so run your claims past a healthcare attorney before they go live.

What Meta’s weight loss ad policy actually says

Meta keeps its weight loss rules on its Health and Wellness policy page. The version we read on September 29 carries a change log entry from July 2026. Four rules do most of the work for a clinic.

Adults only. Ads “promoting or marketing dietary, health, or weight loss or weight gain products and services must be targeted to people at least 18 years or older.”

No attacks on how someone looks. No “statements of inferiority about physical appearance,” which Meta defines as “terms, descriptions, or questions that are negative and attack an individual’s appearance, specific body parts, or hygiene.” A hook asking what you hate about your stomach qualifies.

No fat pinching. Weight loss ads can’t depict a “close up on specific body area by pinching fat.”

No clickbait outcomes. No “sensational language with exaggerated or extreme claims, or promises of specific outcomes within a set timeframe without disclaimers or qualifiers.” “Down 30 pounds by summer” is the shape it describes.

What the page doesn’t contain is a blanket ban on before and after photos. For dietary products like supplements, Meta says an ad aimed at adults can show “its impact of using it, and clearly indicate the time taken to achieve noticeable results.” Prescription weight loss products get sent to a separate policy. If your team’s rule of thumb is “Meta bans before and afters,” check it against the current page, then hold the photo to the FTC’s standard for results claims, covered below.

GLP-1 ads are prescription drug ads on Meta

An ad that sells a GLP-1 prescription falls under Meta’s Drugs and Pharmaceuticals policy. Advertisers “actively certified with LegitScript” can promote prescription drugs if they also get Meta’s authorization and complete its onboarding, target only adults in the United States, Canada or New Zealand where they’re certified, and include “a disclaimer to consult a licensed health professional or obtain a valid prescription.” For telehealth, the page is explicit: “Meta requires online pharmacies and telehealth providers to be actively certified with LegitScript.”

Ads that “educate, advocate or give public service announcements related to prescription drugs,” or “promote telehealth services generally,” skip the written authorization step, though nothing on the page exempts them from the Health and Wellness rules. Our read: an ad that teaches for two lines and ends on “book your GLP-1 consult” is selling a prescription, so plan for the prescription rules.

GLP-1 advertising on Google

Google splits the question in two: can the ad say the drug’s name, and can you bid on it. Its restricted drug terms policy answers both for US campaigns: “you don’t need to be certified in order to use prescription drug terms in ads and landing pages,” but you do need certification to target those terms as keywords. Online pharmacies and telemedicine providers need certification regardless, and for some certifications you may need outside accreditation first, “for example, from LegitScript, NABP, or G2.” Semaglutide and tirzepatide are both on the example list of monitored terms Google links from that page. A keyword like “semaglutide near me” is a certified advertiser’s keyword. And because Google treats prescription drug content as a sensitive interest category for personalized ads, Customer Match and remarketing lists are off the table for those campaigns.

The words that get weight loss clinics in trouble

Here’s each risky phrase and who objects to it.

“Same as,” “generic,” “same active ingredient,” “clinically proven.” In a statement on February 6, 2026, FDA pointed to warning letters sent in the fall of 2025 and spelled out what companies can’t claim in promotional materials: that compounded products are “generic versions or the same as drugs approved by FDA,” that they “use the same active ingredient” as the approved drugs, or that they’re “clinically proven to produce results for the patient.”

“FDA approved,” for anything compounded. FDA’s page on compounding these drugs says it plainly: “Compounded drugs are not approved by FDA.”

“Cure” and “lose 30 pounds in 60 days.” Meta bars claims to “cure, heal, or eliminate” a list of diseases that starts with diabetes, even from a health professional (claims about treating or managing symptoms are exempt), and treats a specific result in a set time without a qualifier as clickbait. The FTC’s Health Products Compliance Guidance, dated December 2022, says claims about the health benefits or safety of drugs need “competent and reliable scientific evidence.”

“Results not typical.” The FTC’s guidance says “attempts to disclaim dramatic results with statements like ‘Results not typical’ don’t cure the deception.” A dramatic testimonial should come with “a clear and conspicuous disclosure of the results a typical consumer can actually expect.” Its worked example is a weight loss supplement ad with before and after photos and a fine print “These results are not typical” line, and the FTC finds that vague disclosure inadequate.

“Dr.” and “doctor.” California’s Business and Professions Code section 2054 makes it a misdemeanor to use “doctor,” “physician” or “Dr.” in an advertisement without a physician and surgeon certificate, with exceptions for some other licensees. It also bars those words “in a health care setting that would lead a reasonable patient to determine that person is a licensed ‘M.D.’ or ‘D.O.’” A federal district court upheld the law in 2025 in Palmer v. Bonta, a challenge from three nurse practitioners with doctorates in nursing practice, and they’ve appealed to the Ninth Circuit. Our rule is simpler: in health care content, no “Dr.” and no “doctor” for anyone who isn’t an MD or DO.

“Painless,” “auto injector,” someone else’s pen name. These are ours, from the September 28 meeting. “Painless” is a promise about a stranger’s body, and the pen words have to be true of the pen in the patient’s hand.

The words we reach for instead:

• “Dosing pen” or “injection pen.”
• “A very fine needle.”
• “You set the dose your provider prescribes and monitors.”
• The title on the provider’s license, exactly as it reads.
• “Call your provider,” at the end of any answer to a medical question.

How we build GLP-1 content for a clinic we work with

We don’t lead with the drug. The clinic’s content leads with the program, the provider and the patient’s experience, like an appetite that disappears or a scale that stops moving. The rules around these drugs keep moving: FDA’s page on compounding them alone carries eight dated updates between October 2024 and April 2026.

We teach the units, never the dose. One script covers units, milligrams and milliliters: “three different things.” It’s built on an FDA alert dated July 26, 2024 on compounded semaglutide, which said confusion between those units may have contributed to dosing errors. Most of the reports described patients drawing up too much from a multiple dose vial, and those patients “administered five to 20 times more than the intended dose.” The caption tells viewers to have a provider walk them through their first one in person. Dosing itself stays in the exam room.

The generator is the backstop. It also stops on “as low as,” “starting at,” ”% off,” “discount,” “free” and “coupon,” because offers go in the DM, not the reel. The written rules printed with the scripts add no promised results, numbers or timelines, no before and after, and a signed release from anyone else on camera.

It’s the same pattern as financial advisor marketing: the assets that persuade best draw the closest reading.

A checklist before a weight loss ad goes live

1. Age targeting is 18 or older.
2. If the ad sells a prescription: LegitScript certification, Meta’s authorization, matching location targeting and the “consult a licensed health professional or obtain a valid prescription” disclaimer.
3. On Google, no drug names in your keywords until you’re certified, and no plan that depends on Customer Match or remarketing.
4. Nothing compounded is called “FDA approved,” “generic,” “the same as” an approved drug, “the same active ingredient” or “clinically proven.”
5. No cure claims, pinched fat, attacks on appearance, or timed results without a qualifier.
6. Every results claim has evidence on file, and every testimonial reflects typical results or clearly says what’s typical.
7. Any before and after passes the same test and has signed patient consent. Our reel scripts for this clinic use none.
8. Provider titles match the license. In California, check section 2054 before anyone but an MD or DO is called “Dr.”
9. The landing page matches the ad’s claims, since Google’s drug term rules cover landing pages too.
10. The prescribing provider has checked clinical accuracy, and a healthcare attorney has checked the claims.

What this doesn’t mean

It doesn’t mean clinics can’t advertise GLP-1 care. Meta and Google both allow prescription drug advertising in the US under conditions, most of which run through certification.

It doesn’t mean compounding is illegal. Under section 503A, the first condition FDA lists is a drug “compounded for an individual patient based on receipt of a prescription.” What changed is the shortage: once one is resolved, FDA says it generally considers the drug commercially available, which limits compounding copies of it. FDA declared the tirzepatide shortage resolved on October 2, 2024, and again on December 19, 2024 after litigation sent it back for review. It declared the semaglutide shortage resolved on February 21, 2025. As of its April 1, 2026 update, neither drug is on FDA’s shortage list or the 503B bulks list. What’s legal to compound is a question for your pharmacy and your attorney. The marketing question is narrower: don’t call it approved, generic or the same.

It doesn’t mean the California title rule is national. Outside California, ask your attorney what your state requires.

FAQ

What is Meta’s ad policy for weight loss?

Meta requires weight loss ads to target people 18 or older, and its Health and Wellness policy bans attacks on a person’s appearance, close ups of pinched fat, and promises of specific results in a set time without qualifiers. Ads for prescription weight loss drugs also fall under Meta’s Drugs and Pharmaceuticals policy.

Can a weight loss clinic run GLP-1 ads on Facebook?

Yes, with conditions. Meta allows prescription drug ads from advertisers actively certified with LegitScript and authorized by Meta, targeted to adults in the United States, Canada or New Zealand, with a disclaimer to consult a licensed health professional or obtain a valid prescription. Ads that only educate, or promote telehealth services generally, don’t need written authorization.

Does Google allow GLP-1 ads?

In the US, Google lets advertisers use prescription drug terms in ads and landing pages without certification, but targeting those terms as keywords requires it. Online pharmacies and telemedicine providers need certification regardless, and some certifications may require accreditation from LegitScript or a similar body first.

Can you say compounded semaglutide is the same as the brand name drug?

No. In February 2026, FDA said companies can’t claim in promotional materials that compounded products are generic versions of approved drugs or the same as them, can’t say they use the same active ingredient, and can’t call them clinically proven to produce results. FDA also states that compounded drugs aren’t approved by FDA.

Can weight loss ads use before and after photos?

Meta’s current Health and Wellness text has no blanket ban, but it bars fat pinching close ups and timed results without qualifiers, and prescription products also fall under its drug policy. Under FTC guidance, a dramatic result needs a clear disclosure of what a typical patient can expect, and “results not typical” doesn’t fix a misleading one.

Can a nurse practitioner be called “Dr.” in California health care ads?

California’s Business and Professions Code section 2054 bars “doctor,” “physician” and “Dr.” in advertising without a physician and surgeon certificate, with limited exceptions, and in any health care setting where a reasonable patient would take the person for an MD or DO. A federal district court upheld the law in 2025 in Palmer v. Bonta, a challenge from nurse practitioners with doctorates, and they’ve appealed to the Ninth Circuit.

Build the brand on what you control

You don’t control FDA’s next update or Meta’s next change log. You do control who the patient meets and what happens after the first visit. Put your ads and your content there, and most of the rules above stop feeling like walls. It’s how we approach medical practice marketing wherever a regulator reads the claims.

Want a second opinion on your clinic’s ads and content? Book a 15-minute call. No deck, no fluff. Strategy first. Tactics second. The work works.

Reliable PR & Marketing is a strategy-first marketing agency in Bakersfield, California. We run integrated SEO, PR, web, and content for founder-led companies across Kern County and nationwide. Strategy first. Execution always.